Boardroom Alpha
Start trial
10-K primary document
BYSI · Annual Report (Form 10-K) · Filed March 25, 2026

Beyondspring Inc — 10-K exhibit

ex_934877.htm
Beyondspring Inc on Boardroom Alpha
ex_934877.htm

Exhibit 10.17

 

 

exh1018logo.jpg

 

November 12, 2025

 

 

Dear June(Yingjuan Lu),

 

I am pleased to inform you that effective December 1, 2025, your new annual base salary at BeyondSpring will be $280,000. The Company may change your position, duties, and work location from time to time at its discretion.

 

Congratulations on this well-deserved increase!

 

We understand that your contributions to our organization have been invaluable, and we are committed to recognizing and rewarding your hard work and dedication. This adjustment reflects the value that we place on your contributions and our commitment to providing competitive compensation to our employees.

 

We appreciate your continued commitment to our company’s success and your dedication to your role. Your contributions are an important part of our ongoing growth, and we are thrilled to have you on our team.

 

Once again, congratulations on your salary adjustment, and we look forward to your continued success and leadership at BeyondSpring.

 

 

Sincerely,

 

/s/ Lan Huang                           

Lan Huang

CEO & Co-Founder

BeyondSpring Pharmaceuticals, Inc

 

 

 

 

BeyondSpring Pharmaceuticals, Inc. | 100 Campus Drive, STE 410 | Florham Park, NJ 07932 Main Tel: (646) 305-6387

www.beyondspringpharma.com

 

 

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer